← Back to Screener
Structure Therapeutics Inc. American Depositary Shares (GPCR)
Price$48.22
Favorite Metrics
Price vs S&P 500 (26W)60.03%
Price vs S&P 500 (4W)-5.05%
Market Capitalization$3.79B
All Metrics
Book Value / Share (Quarterly)$7.14
P/TBV (Annual)28.17x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-1.06
Price vs S&P 500 (YTD)-31.17%
EPS (TTM)$-0.83
10-Day Avg Trading Volume0.87M
EPS Excl Extra (TTM)$-0.83
EPS (Annual)$-0.80
ROI (Annual)-9.31%
Cash / Share (Quarterly)$6.81
ROA (Last FY)-8.91%
EBITD / Share (TTM)$-0.99
ROE (5Y Avg)-28.20%
Cash Flow / Share (Annual)$-1.06
P/B Ratio2.50x
P/B Ratio (Quarterly)2.71x
Net Income / Employee (Annual)$-1
Net Interest Coverage (TTM)-308.98x
ROA (TTM)-13.78%
EPS Incl Extra (Annual)$-0.80
Current Ratio (Annual)24.81x
Quick Ratio (Quarterly)24.43x
3-Month Avg Trading Volume1.35M
52-Week Price Return173.88%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$5.03
52-Week High$94.90
EPS Excl Extra (Annual)$-0.80
CapEx CAGR (5Y)185.66%
26-Week Price Return68.77%
Quick Ratio (Annual)24.43x
13-Week Price Return-39.82%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)24.81x
Enterprise Value$2,990.192
Revenue / Employee (Annual)$0
Cash / Share (Annual)$6.81
3-Month Return Std Dev59.80%
Net Income / Employee (TTM)$-1
ROE (Last FY)-9.31%
EPS Basic Excl Extra (Annual)$-0.80
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.83
ROI (TTM)-14.55%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$2.32
Price vs S&P 500 (52W)138.79%
Year-to-Date Return-27.03%
5-Day Price Return-6.45%
EPS Normalized (Annual)$-0.80
ROA (5Y Avg)-25.55%
Month-to-Date Return5.29%
Cash Flow / Share (TTM)$-2.24
EBITD / Share (Annual)$-0.99
ROI (5Y Avg)-28.20%
EPS Basic Excl Extra (TTM)$-0.83
P/TBV (Quarterly)12.38x
P/B Ratio (Annual)2.71x
Book Value / Share (Annual)$7.14
Price vs S&P 500 (13W)-42.69%
Beta-1.25x
Revenue / Share (TTM)$0.00
ROE (TTM)-14.55%
52-Week Low$15.80
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
GPCRStructure Therapeutics Inc. American Depositary Shares | — | — | — | — | $48.22 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Structure Therapeutics is a clinical-stage biopharmaceutical company developing oral small-molecule therapeutics targeting G-protein coupled receptors (GPCRs) for chronic diseases with unmet medical needs. The company's differentiated platform integrates structure-based drug discovery with computational chemistry expertise to advance its pipeline of potential medicines.